Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen

Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.
Read More
Paper finds gaps in health data are a barrier to health equity

COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / Pacific Islanders are up to 2.5 times higher as compared to whites....
Read More
New research shows hotspots of inequity relate to increased COVID-19 hospitalizations

As part of PhRMA’s continuing work to address health inequities, we are partnering with researchers to study hotspots of COVID-19 and chronic disease inequities in New York state. Reports this summer...
Read More
Increasing diversity at investigator sites could increase minority participation in clinical trials

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
New report highlights biopharmaceutical industry’s commitment to D&I

Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the workplace,...
Read More
Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US

This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. Outside...
Read More
PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence

Systemic racism is as real as any disease, and our industry is not immune. This summer, in the wake of a national outcry for racial and social justice, our industry offered a firm stance – systemic...
Read More
Committing to diversity, equity and inclusion: A call to action for clinical trials

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Just released: PhRMA members’ new clinical trial diversity principles

Yesterday, PhRMA published first ever industry-wide principles on clinical trial diversity, a new chapter in the already existing “Principles on Conduct of Clinical Trials & Communication of Clinical...
Read More
ICYMI – Addressing health inequities: Biopharmaceutical companies are rising to the occasion

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More